SaLudo: a randomized phase IIb/III study of lurbinectedin plus doxorubicin as first-line treatment in leiomyosarcoma
SaLudo:一项随机 IIb/III 期研究,评估 lurbinectedin 联合多柔比星作为平滑肌肉瘤一线治疗方案的疗效
期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2463798
Cote, Gregory M; Chawla, Sant P; Demetri, George; Kasper, Bernd; Jones, Robin L; Broto, Javier Martin; Wooley, Joseph; Weiss, Mia C; Tafuto, Salvatore; Badalamenti, Giuseppe; Carrasco, Irene; Peinado, Paloma; Blay, Jean-Yves; Boggio, Gaston; Fernandez, Cristian; Nieto, Antonio; Kahatt, Carmen; Alfaro, Vicente; Le Cesne, Axel